Aprogen pharmaceuticals,Inc. (003060.KS)
KRW 704.0
(-4.22%)
KRW 704.0
(-4.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -33.65 Billion | 25.72 Billion | -6.22 Billion | 8.08 Billion | 713.73 Million | 1.33 Billion |
| Net Income | -118.26 Billion | 5.58 Billion | 9.15 Billion | 18.91 Billion | -3.46 Billion | -1.21 Billion |
| Depreciation & Amortization | 21.39 Billion | 2.4 Billion | 2.07 Billion | 1.93 Billion | 1.66 Billion | 1.46 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -11.98 Billion | 13.9 Billion | -15.76 Billion | -1.2 Billion | -175.2 Million | 608.7 Million |
| Other non-cash items | 75.21 Billion | 3.83 Billion | -1.68 Billion | -11.55 Billion | 2.69 Billion | 471.95 Million |
| Investing Cash Flow | -60.19 Billion | -53 Billion | -23.15 Billion | -195.26 Billion | -70.46 Billion | -58.1 Billion |
| Investments in PPE | -28.39 Billion | -1.54 Billion | -1.44 Billion | -1.42 Billion | -2.42 Billion | -2.24 Billion |
| Acquisitions | 25.8 Billion | 5.07 Billion | -79.23 Million | 10.22 Billion | 14.54 Billion | -32.28 Billion |
| Investment purchases | -101.01 Billion | -115.02 Billion | -340.11 Billion | -310 Billion | -130 Billion | -40.03 Billion |
| Sales/Maturities of investments | 21.32 Billion | 135.21 Billion | 415.04 Billion | 229.26 Billion | 86.99 Billion | 31.56 Billion |
| Other Investing Activities | 22.08 Billion | -76.72 Billion | -96.56 Billion | -123.33 Billion | -39.59 Billion | -15.11 Billion |
| Financing Cash Flow | 80.27 Billion | 15.78 Billion | -350.25 Million | 221.7 Billion | 78.44 Billion | 54.61 Billion |
| Debt repayment | -19.49 Billion | -4.07 Billion | -113.9 Million | -171.78 Million | -31.8 Billion | -15.57 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -4.42 Billion | - | - | - | - | - |
| Common Stock Issuance | 61.1 Billion | 244.37 Thousand | -955.24 Thousand | 235.37 Billion | 106.06 Billion | 70.07 Billion |
| Other Financing Activities | 4.45 Billion | 19.86 Billion | -235.39 Million | -13.5 Billion | 4.18 Billion | 115.53 Million |
| Accounts receivables | 1.12 Billion | 69.05 Million | -631.64 Million | 1.16 Billion | 1.34 Billion | 1.25 Billion |
| Accounts payables | -2.37 Billion | 313.45 Million | -155.62 Million | 272.34 Million | -247.01 Million | 218.38 Million |
| Inventory | -3.28 Billion | -1.18 Billion | -1.02 Billion | -1.6 Billion | -682.13 Million | 276.76 Million |
| Other working capital | -7.45 Billion | 14.7 Billion | -13.95 Billion | -1.03 Billion | -595.1 Million | 331.94 Million |
| Cash at beginning of period | 23.6 Billion | 35.07 Billion | 64.79 Billion | 30.29 Billion | 21.63 Billion | 23.78 Billion |
| Cash at end of period | 10.05 Billion | 23.6 Billion | 35.07 Billion | 64.79 Billion | 30.29 Billion | 21.63 Billion |
| Capital Expenditure | -28.39 Billion | -1.54 Billion | -1.44 Billion | -1.42 Billion | -2.42 Billion | -2.24 Billion |
| Effect of forex changes on cash | 11.64 Million | 25.03 Million | 11.01 Million | -24.82 Million | -21.19 Million | 10.41 Million |
| Net cash flow / Change in cash | -13.55 Billion | -11.46 Billion | -29.72 Billion | 34.49 Billion | 8.66 Billion | -2.15 Billion |
| Free Cash Flow | -62.04 Billion | 24.18 Billion | -7.66 Billion | 6.66 Billion | -1.7 Billion | -912.93 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -23.47 Billion | -6.01 Billion | -96.8 Billion | -118.26 Billion | -3.28 Billion | -17.56 Billion |
| Depreciation & Amortization | 4.25 Billion | 4.43 Billion | 5.29 Billion | 21.39 Billion | 5.31 Billion | 5.36 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -835.92 Million | 1.68 Billion | 804.02 Million | -11.98 Billion | 4.09 Billion | -7.27 Billion |
| Other non-cash items | 11.77 Billion | 3.11 Billion | 84.76 Billion | 75.21 Billion | -8.79 Billion | 9.16 Billion |
| Investing Cash Flow | -12.61 Billion | 2.23 Billion | 2.15 Billion | -60.19 Billion | -57.73 Billion | -10.88 Billion |
| Investments in PPE | -2.23 Billion | -2.5 Billion | 22.31 Billion | -28.39 Billion | -11.58 Billion | -3.79 Billion |
| Acquisitions | - | 13.9 Million | 25.8 Billion | 25.8 Billion | -7.1 Billion | -499.99 Million |
| Investment purchases | - | - | -54.01 Billion | -101.01 Billion | -30 Billion | -7.02 Billion |
| Sales/Maturities of investments | - | 3.48 Billion | 13.48 Billion | 21.32 Billion | 7.34 Billion | 499.99 Million |
| Other Investing Activities | -10.37 Billion | 1.24 Billion | -5.43 Billion | 22.08 Billion | -16.38 Billion | -76.35 Million |
| Financing Cash Flow | 34.95 Billion | 1.9 Billion | 2.72 Billion | 80.27 Billion | 51.53 Billion | 26.69 Billion |
| Debt repayment | -151.97 Million | -2.6 Billion | -1.51 Billion | -19.49 Billion | -6.5 Billion | -73 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -21.72 Million | - | -2049.00 | -4.42 Billion | -10.24 Million | -3.91 Million |
| Common Stock Issuance | 53.62 Billion | -161.48 Million | -125.81 Million | 61.1 Billion | 14.24 Million | 44.2 Billion |
| Other Financing Activities | 34.82 Billion | -161.48 Million | 4.45 Billion | 4.45 Billion | 58.02 Billion | 99.7 Billion |
| Accounts receivables | 798.46 Million | 1.9 Billion | 1.38 Billion | 1.12 Billion | 8.06 Billion | -8.55 Billion |
| Accounts payables | -241.9 Million | 2.02 Billion | -2.11 Billion | -2.37 Billion | -309.64 Million | -3.5 Billion |
| Inventory | -3.93 Billion | -2.92 Billion | 2.15 Billion | -3.28 Billion | -226.34 Million | 4.55 Billion |
| Other working capital | 2.3 Billion | 676.82 Million | -613.73 Million | -7.45 Billion | -3.43 Billion | 219.6 Million |
| Cash at beginning of period | 9.55 Billion | 10.05 Billion | 11.1 Billion | 23.6 Billion | 19.97 Billion | 14.47 Billion |
| Cash at end of period | 23.63 Billion | 9.55 Billion | 10.05 Billion | 10.05 Billion | 11.1 Billion | 19.97 Billion |
| Capital Expenditure | -2.23 Billion | -2.5 Billion | 22.31 Billion | -28.39 Billion | -11.58 Billion | -3.79 Billion |
| Effect of forex changes on cash | 15.35 Million | 2.84 Million | -3.74 Million | 11.64 Million | 8.61 Million | -95.41 Thousand |
| Net cash flow / Change in cash | 14.07 Billion | -494.86 Million | -1.05 Billion | -13.55 Billion | -8.86 Billion | 5.49 Billion |
| Free Cash Flow | -10.51 Billion | -7.14 Billion | 16.38 Billion | -62.04 Billion | -14.25 Billion | -14.1 Billion |
HEXABS
7751
3306
1701
PIA
GNA